Average Co-Inventor Count = 4.61
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Institut Pasteur (15 from 870 patents)
2. Centre National De La Recherche Scientifique (10 from 5,089 patents)
3. Commissariat À L'Énergie Atomique Et Aux Énergies Alternatives (5 from 4,874 patents)
4. F. Hoffmann-la Roche Ag (5 from 168 patents)
5. Institut National De La Sante Et De La Recherche Medicale (1 from 1,744 patents)
15 patents:
1. 12326451 - Severe acute respiratory syndrome (SARS)—associated coronavirus diagnostics
2. 11815513 - Severe acute respiratory syndrome (SARS)-associated coronavirus diagnostics
3. 11339211 - Nanobodies suitable for neuron regeneration therapy
4. 11124563 - Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof
5. 10948490 - Severe acute respiratory syndrome (SARS)—associated coronavirus diagnostics
6. 10787505 - Oligopeptide and methods for producing conjugates thereof
7. 10640552 - Nanobodies suitable for neuron regeneration therapy
8. 10591466 - In vitro blood-brain barrier model
9. 10538582 - Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof
10. 10174105 - Use of VHH antibodies for the preparation of peptide vectors for delivering a substance of interest and their applications
11. 10155054 - Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins
12. 10087245 - Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof
13. 9738712 - Camelid single-domain antibody directed against amyloid beta and methods for producing conjugates thereof
14. 9387260 - VHH antibodies used as peptide vectors for delivering a substance of interest
15. 8460888 - Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins